SCHEMBL26257703

SCHEMBL26257703

COCc1ccc(C2(c3ccc(COC)cc3)c3ccccc3C(=O)c3ccccc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.43
LMNA P02545 3/20 0.42
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 1/20 0.42
OPRK1 P41145 1/20 0.42
KMT2A Q03164 1/20 0.42
TUBB4A P04350 1/20 0.40
TUBB P07437 1/20 0.40
TUBA3C P0DPH7 1/20 0.40
TUBA1B P68363 1/20 0.40
TUBA4A P68366 1/20 0.40
TUBB4B P68371 1/20 0.40
TUBB3 Q13509 1/20 0.40
TUBB2A Q13885 1/20 0.40
TUBB8 Q3ZCM7 1/20 0.40
TUBA3E Q6PEY2 1/20 0.40
TUBA1A Q71U36 1/20 0.40
TUBA1C Q9BQE3 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19002147 0.90 MEN1 (0.52) PDK2LMNAMAPTSMN1; SMN2KDM4E
SCHEMBL25986507 0.79 MAPT (0.48) LMNAMAPTSMN1; SMN2KDM4EMEN1
SCHEMBL13497452 0.77 LMNA (0.50) PDK2LMNAMAPTSMN1; SMN2KDM4E
SCHEMBL30289963 0.76 MEN1 (0.54) LMNAMAPTSMN1; SMN2KDM4EMEN1
SCHEMBL649568 0.76 MEN1 (0.54) LMNAMAPTSMN1; SMN2KDM4EMEN1
SCHEMBL25919752 0.76 KMT2A (0.50) LMNAMAPTSMN1; SMN2KDM4EMEN1
SCHEMBL31513318 0.76 MEN1 (0.43) PDK2LMNAMAPTSMN1; SMN2KDM4E
SCHEMBL21858091 0.76 MEN1 (0.43) PDK2LMNAMAPTSMN1; SMN2KDM4E
SCHEMBL26257701 0.76 PDK2 (0.50) PDK2LMNAMAPTSMN1; SMN2KDM4E
SCHEMBL30805724 0.75 MEN1 (0.52) LMNAMAPTSMN1; SMN2KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760712-B2 Triarylmethane compounds MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11760712-B2 Triarylmethane compounds CBR3, HAX1, HRH3 PDK2 4076/4885LMNA 1611/4885MAPT 4486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.